The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1
Open accessAbstract
PARP-1, PARP-2 and PARP-3 are DNA-dependent PARPs that localize to DNA damage, synthesize poly(ADP-ribose) (PAR) covalently attached to target proteins including themselves, and thereby recruit repair factors to DNA breaks to increase repair efficiency. PARP-1, PARP-2 and PARP-3 have in common two C-terminal domains-Trp-Gly-Arg (WGR) and catalytic (CAT). In contrast, the N-terminal region (NTR) of PARP-1 is over 500 residues and includes four regulatory domains, whereas PARP-2 and PARP-3 have smaller NTRs (70 and 40 residues, respectively) of unknown structural composition and function. Here, we show that PARP-2 and PARP-3 are preferentially activated by DNA breaks harboring a 5' phosphate (5'P), suggesting selective activation in response to specific DNA repair intermediates, in particular structures that are competent for DNA ligation. In contrast to PARP-1, the NTRs of PARP-2 and PARP-3 are not strictly required for DNA binding or for DNA-dependent activation. Rather, the WGR domain is the central regulatory domain of PARP-2 and PARP-3. Finally, PARP-1, PARP-2 and PARP-3 share an allosteric regulatory mechanism of DNA-dependent catalytic activation through a local destabilization of the CAT. Collectively, our study provides new insights into the specialization of the DNA-dependent PARPs and their specific roles in DNA repair pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
Amé, J., Spenlehauer, C., & de Murcia, G. (2004) · BioEssays · doi:10.1002/bies.20085 · Cited by 1,459
Toward a unified nomenclature for mammalian ADP-ribosyltransferases
Hottiger, M. O., Hassa, P. O., Lüscher, B., Schüler, H., & Koch-Nolte, F. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.12.003 · Cited by 811
PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase
Amé, J.-C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., Muller, S., Höger, T., Murcia, J. M.-D., & de Murcia, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17860 · Cited by 745
Schreiber, V., Amé, J.-C., Dollé, P., Schultz, I., Rinaldi, B., Fraulob, V., Ménissier-de Murcia, J., & de Murcia, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202390200 · Cited by 705
Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2012) · Science · doi:10.1126/science.1216338 · Cited by 665
Self-citationMenissier de Murcia, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg206 · Cited by 627
PARP1-dependent Kinetics of Recruitment of MRE11 and NBS1 Proteins to Multiple DNA Damage Sites
Haince, J.-F., McDonald, D., Rodrigue, A., Déry, U., Masson, J.-Y., Hendzel, M. J., & Poirier, G. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706734200 · Cited by 608
PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination
Bryant, H. E., Petermann, E., Schultz, N., Jemth, A., Loseva, O., Issaeva, N., Johansson, F., Fernandez, S., McGlynn, P., & Helleday, T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.206 · Cited by 602
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
D’Amours, D., Desnoyers, S., D’Silva, I., & Poirier, G. G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420249 · Cited by 599
SAP – a putative DNA-binding motif involved in chromosomal organization
Aravind, L., & Koonin, E. V. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01537-6 · Cited by 512
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
De Vos, M., Schreiber, V., & Dantzer, F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.018 · Cited by 492
Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins
Ahel, I., Ahel, D., Matsusaka, T., Clark, A. J., Pines, J., Boulton, S. J., & West, S. C. (2008) · Nature · doi:10.1038/nature06420 · Cited by 429
Human DNA ligase I completely encircles and partially unwinds nicked DNA
Pascal, J. M., O'Brien, P. J., Tomkinson, A. E., & Ellenberger, T. (2004) · Nature · doi:10.1038/nature03082 · Cited by 352
Self-citationSubstrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-Ribosylation
Kleine, H., Poreba, E., Lesniewicz, K., Hassa, P. O., Hottiger, M. O., Litchfield, D. W., Shilton, B. H., & Lüscher, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.009 · Cited by 338
PARP-3 and APLF Function Together to Accelerate Nonhomologous End-Joining
Rulten, S. L., Fisher, A. E. O., Robert, I., Zuma, M. C., Rouleau, M., Ju, L., Poirier, G., Reina-San-Martin, B., & Caldecott, K. W. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.006 · Cited by 326
Altmeyer, M., Messner, S., Hassa, P. O., Fey, M., & Hottiger, M. O. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp229 · Cited by 325
Mortusewicz, O., Amé, J.-C., Schreiber, V., & Leonhardt, H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm933 · Cited by 316
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
Sharifi, R., Morra, R., Denise Appel, C., Tallis, M., Chioza, B., Jankevicius, G., Simpson, M. A., Matic, I., Ozkan, E., Golia, B., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.51 · Cited by 304
Boehler, C., Gauthier, L. R., Mortusewicz, O., Biard, D. S., Saliou, J.-M., Bresson, A., Sanglier-Cianferani, S., Smith, S., Schreiber, V., Boussin, F., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016574108 · Cited by 277
Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202507 · Cited by 239
Self-citationIkejima, M., Noguchi, S., Yamashita, R., Ogura, T., Sugimura, T., Gill, D. M., & Miwa, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45824-3 · Cited by 238
PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis
Langelier, M.-F., & Pascal, J. M. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.01.003 · Cited by 215
Self-citationLangelier, M.-F., Servent, K. M., Rogers, E. E., & Pascal, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708558200 · Cited by 204
Self-citationRegulation of Poly(ADP-ribose) Polymerase-1 by DNA Structure-specific Binding
Lonskaya, I., Potaman, V. N., Shlyakhtenko, L. S., Oussatcheva, E. A., Lyubchenko, Y. L., & Soldatenkov, V. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413483200 · Cited by 186
Eustermann, S., Videler, H., Yang, J.-C., Cole, P. T., Gruszka, D., Veprintsev, D., & Neuhaus, D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.034 · Cited by 174
Langelier, M.-F., Ruhl, D. D., Planck, J. L., Kraus, W. L., & Pascal, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105668 · Cited by 167
Self-citationTao, Z., Gao, P., & Liu, H.-W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906135d · Cited by 166
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
Isabelle, M., Moreel, X., Gagné, J.-P., Rouleau, M., Ethier, C., Gagné, P., Hendzel, M. J., & Poirier, G. G. (2010) · Proteome Science · doi:10.1186/1477-5956-8-22 · Cited by 164
ATP for the DNA Ligation Step in Base Excision Repair Is Generated from Poly(ADP-ribose)
Oei, S. L., & Ziegler, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002429200 · Cited by 147
Beck, C., Boehler, C., Guirouilh‐Barbat, J., Bonnet, M.-E., Illuzzi, G., Rondé, P., Gauthier, L., Magroun, N., Rajendran, A., López, B. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku174 · Cited by 139
PARP‐3 associates with polycomb group bodies and with components of the DNA damage repair machinery
Rouleau, M., McDonald, D., Gagné, P., Ouellet, M. ‐., Droit, A., Hunter, J. M., Dutertre, S., Prigent, C., Hendzel, M. J., & Poirier, G. G. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21051 · Cited by 133
D’Silva, I., Pelletier, J. D., Lagueux, J., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(98)00278-7 · Cited by 107
Tao, Z., Gao, P., Hoffman, D. W., & Liu, H. (2008) · Biochemistry · doi:10.1021/bi800018a · Cited by 98
Langelier, M.-F., Planck, J. L., Servent, K. M., & Pascal, J. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-270-0_13 · Cited by 98
Self-citationMapping PARP-1 Auto-ADP-ribosylation Sites by Liquid Chromatography–Tandem Mass Spectrometry
Chapman, J. D., Gagné, J., Poirier, G. G., & Goodlett, D. R. (2013) · Journal of Proteome Research · doi:10.1021/pr301219h · Cited by 92
Targeting PARP-1 Allosteric Regulation Offers Therapeutic Potential against Cancer
Steffen, J. D., Tholey, R. M., Langelier, M.-F., Planck, J. L., Schiewer, M. J., Lal, S., Bildzukewicz, N. A., Yeo, C. J., Knudsen, K. E., Brody, J. R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1701 · Cited by 66
Self-citationARTD2 activity is stimulated by RNA
Léger, K., Bär, D., Savić, N., Santoro, R., & Hottiger, M. O. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku131 · Cited by 52
Poly(ADP-ribose) Polymerase-1 Dimerizes at a 5‘ Recessed DNA End in Vitro: A Fluorescence Study
Pion, E., Bombarda, E., Stiegler, P., Ullmann, G. M., Mély, Y., de MURCIA, G., & Gérard, D. (2003) · Biochemistry · doi:10.1021/bi0344432 · Cited by 49
PARP-2: Structure-Function Relationship
Schreiber, V., Ricoul, M., Amé, J., Dantzer, F., Meder, V., Spenlehauer, C., Stiegler, P., Niedergang, C., Sabatier, L., Favaudon, V., et al. (2006) · Springer eBooks · doi:10.1007/0-387-36005-0_2 · Cited by 16
Cited by
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Pommier, Y., O’Connor, M. J., & de Bono, J. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9246 · Cited by 739
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681
“Moreover, while PARP-2 and PARP-3 share the allosteric activation mechanismwith PARP-1, they require 5′ phosphorylation at the DNA breaks for activation, unlike PARP-1 (Langelier et al. 2014).”
BackgroundPARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Rose, M., Burgess, J. T., O’Byrne, K., Richard, D. J., & Bolderson, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564601 · Cited by 719
PARP inhibitor resistance: the underlying mechanisms and clinical implications
Li, H., Liu, Z.-Y., Wu, N., Chen, Y.-C., Cheng, Q., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01227-0 · Cited by 539
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Dias, M. P., Moser, S. C., Ganesan, S., & Jonkers, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00532-x · Cited by 505
Metadata
- Authors
- Langelier, M.-F., Riccio, A. A., & Pascal, J. M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-13
- Volume
- 42
- Issue
- 12
- Pages
- 7762-7775
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2039855253
- Cited by
- 265
- References
- 41
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.